Who are the key players in the Afluria Quadrivalent Market Report 2026 market?

Major companies operating in the Afluria Quadrivalent Market Report 2026 market are Major companies operating in the afluria quadrivalent market are Seqirus Inc. Read More

What are the major opportunities in the Afluria Quadrivalent market? What are the strategies for the Afluria Quadrivalent market?

For detailed insights on the major opportunities and strategies in the Afluria Quadrivalent market, Read More

How does the Afluria Quadrivalent market relate to the overall economy and other similar markets?

For detailed insights on Afluria Quadrivalent's relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the Afluria Quadrivalent industry?

For detailed insights on the mergers and acquisitions in the Afluria Quadrivalent industry, Read More

What are the key dynamics influencing the Afluria Quadrivalent market growth? SWOT analysis of the Afluria Quadrivalent market.

For detailed insights on the key dynamics influencing the Afluria Quadrivalent market growth and SWOT analysis of the Afluria Quadrivalent industry, Read More

Afluria Quadrivalent Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Afluria Quadrivalent Market Report 2026

Name: Afluria Quadrivalent Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Afluria Quadrivalent Market Overview

• The Afluria Quadrivalent market growth in the historic period has been driven by limitations of trivalent influenza vaccines, recurring multi-strain flu outbreaks

• Market expansion is supported by demand for broader strain coverage, increasing healthcare worker immunization

• Growth Driver: Impact Of Rising Influenza Prevalence On The Growth Of The Afluria Quadrivalent Market

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Afluria Quadrivalent Market?

Afluria quadrivalent is a vaccine used to prevent infection from four different strains of the influenza virus: two strains of influenza A (H1N1 and H3N2) and two strains of influenza B. It is designed to protect against the flu during the flu season, which typically occurs annually. Afluria quadrivalent is administered via injection and is approved for use in individuals aged 6 months and older.

The main clinical indications of afluria quadrivalent are seasonal influenza prophylaxis, high-risk population immunization, pediatric influenza prophylaxis, healthcare worker immunization. Seasonal Influenza Prophylaxis refers to the preventive use of vaccines, like the Afluria Quadrivalent, to reduce the risk of contracting seasonal influenza caused by the circulating strains of the influenza virus. The routes of administration are injection and nasal spray. The various age groups include adults, geriatric, and pediatrics, and distribution channels include hospitals and retail pharmacies, government suppliers, and others. The different end users encompass hospitals, public, private, clinics, and others.

Afluria Quadrivalent Market Global Report 2026 Market Report bar graph

What Is The Afluria Quadrivalent Market Size and Share 2026?

The growth in the historic period can be attributed to limitations of trivalent influenza vaccines, recurring multi-strain flu outbreaks, rising hospitalization rates from influenza, established immunization schedules, public sector vaccination programs.

What Is The Afluria Quadrivalent Market Growth Forecast?

The growth in the forecast period can be attributed to demand for broader strain coverage, increasing healthcare worker immunization, growth in pediatric vaccination programs, expansion of government procurement, innovation in vaccine delivery formats. Major trends in the forecast period include rising adoption of quadrivalent influenza vaccines, expanded protection against multiple flu strains, increased vaccination of high-risk populations, growth of government immunization initiatives, advancements in vaccine formulation technologies.

Book your 30 minutes free consultation with our research experts

Global Afluria Quadrivalent Market Segmentation

1) By Clinical Indication: Seasonal Influenza Prophylaxis, High-Risk Population Immunization, Pediatric Influenza Prophylaxis, Healthcare Worker Immunization

2) By Route Of Administration: Injection, Nasal Spray

3) By Age Group: Adults, Geriatric, Pediatrics

4) By Distribution Channel: Hospital And Retail Pharmacies, Government Suppliers, Other Channels

5) By End-User: Hospitals, Public, Private, Clinics, Other End-Users

What Are The Drivers Of The Afluria Quadrivalent Market?

The increasing prevalence of influenza is expected to propel the growth of the afluria quadrivalent market going forward. Influenza is a contagious respiratory illness caused by influenza viruses that can lead to mild to severe illness, including fever, cough, and body aches. The increasing prevalence of influenza is driven by factors such as the annual mutation of the virus, seasonal environmental conditions, and low vaccination coverage in certain populations. Afluria Quadrivalent plays a crucial role in combating the increasing prevalence of influenza by providing protection against four circulating flu strains, thereby reducing the risk of infection and mitigating the impact of seasonal outbreaks. For instance, in November 2024, according to the UK Health Security Agency, a UK-based government agency, influenza positivity rates in week 46 showed an increase, with a weekly average positivity rate of 3.9%, up from 3.3% the previous week. The highest positivity rates were observed in individuals aged 5 to 14, where the weekly average reached 11.6%, a rise from 8.8% in the previous week (week 45). Therefore, the increasing prevalence of influenza will drive the growth of the afluria quadrivalent industry.

Increasing birth rates are expected to propel the growth of the afluria quadrivalent market going forward. The increase in birth rates can be attributed to various factors, including improved healthcare, government incentives, and changing societal attitudes. A higher number of births leads to a larger pediatric population that requires immunization. As birth rates rise, healthcare systems need to administer vaccines to more children to prevent influenza, leading to increased demand for vaccines like Afluria Quadrivalent. For instance, in October 2024, according to the Australian Bureau of Statistics, an Australia-based government agency, there were 24,737 Aboriginal and Torres Strait Islander births registered in 2023, an increase of 349 babies from 2022. Thus, increasing birth rates are driving the growth of the afluria quadrivalent industry.

The rising healthcare expenditure is expected to drive the growth of the afluria quadrivalent market going forward. Healthcare expenditure is the total spending on medical services, treatments, and healthcare resources, funded by governments, insurers, and individuals to ensure accessible and quality care. Afluria Quadrivalent benefits from rising healthcare expenditure as increase in funding enables broader access to seasonal influenza vaccination. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, reported that total healthcare expenditure saw a 5.6% increase in nominal terms from 2022 to 2023, marking a significant acceleration compared to the 0.9% growth observed in 2022. Therefore, the rising healthcare expenditure is driving the growth of the afluria quadrivalent industry.

Key Players In The Global Afluria Quadrivalent Market

Major companies operating in the afluria quadrivalent market are Seqirus Inc.

Need data on a specific region in this market?

Request Regional Data

Regional Insights

North America was the largest region in the afluria quadrivalent market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Afluria Quadrivalent Market?

The afluria quadrivalent consists of sales of pre-filled syringes, vaccine vials, adjuvanted and unadjuvanted versions, flu vaccine kits, related packaging, and storage equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Afluria Quadrivalent Market Report 2026?

The afluria quadrivalent market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the afluria quadrivalent industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Afluria Quadrivalent Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$ billion
Revenue Forecast In 2035	$ billion
Growth Rate	No CAGR found from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Clinical Indication, Route Of Administration, Age Group, Distribution Channel, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Seqirus Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Afluria Quadrivalent Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Afluria Quadrivalent Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Afluria Quadrivalent Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Afluria Quadrivalent Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Rising Adoption Of Quadrivalent Influenza Vaccines

4.2.2 Expanded Protection Against Multiple Flu Strains

4.2.3 Increased Vaccination Of High-Risk Populations

4.2.4 Growth Of Government Immunization Initiatives

4.2.5 Advancements In Vaccine Formulation Technologies

5. Afluria Quadrivalent Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Public Health Institutions

5.4 Pediatric Care Centers

5.5 Geriatric Care Facilities

6. Afluria Quadrivalent Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Afluria Quadrivalent Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Afluria Quadrivalent PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Afluria Quadrivalent Market Size, Comparisons And Growth Rate Analysis

7.3. Global Afluria Quadrivalent Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Afluria Quadrivalent Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Afluria Quadrivalent Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Afluria Quadrivalent Market Segmentation

9.1. Global Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Seasonal Influenza Prophylaxis, High-Risk Population Immunization, Pediatric Influenza Prophylaxis, Healthcare Worker Immunization

9.2. Global Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Injection, Nasal Spray

9.3. Global Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adults, Geriatric, Pediatrics

9.4. Global Afluria Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital And Retail Pharmacies, Government Suppliers, Other Channels

9.5. Global Afluria Quadrivalent Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Public, Private, Clinics, Other End-Users

10. Afluria Quadrivalent Market Regional And Country Analysis

10.1. Global Afluria Quadrivalent Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Afluria Quadrivalent Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Afluria Quadrivalent Market

11.1. Asia-Pacific Afluria Quadrivalent Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Afluria Quadrivalent Market, Segmentation By Clinical Indication, Segmentation By Route Of Administration, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Afluria Quadrivalent Market

12.1. China Afluria Quadrivalent Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Afluria Quadrivalent Market, Segmentation By Clinical Indication, Segmentation By Route Of Administration, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Afluria Quadrivalent Market

13.1. India Afluria Quadrivalent Market, Segmentation By Clinical Indication, Segmentation By Route Of Administration, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Afluria Quadrivalent Market

14.1. Japan Afluria Quadrivalent Market Overview

14.2. Japan Afluria Quadrivalent Market, Segmentation By Clinical Indication, Segmentation By Route Of Administration, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Afluria Quadrivalent Market

15.1. Australia Afluria Quadrivalent Market, Segmentation By Clinical Indication, Segmentation By Route Of Administration, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Afluria Quadrivalent Market

16.1. South Korea Afluria Quadrivalent Market Overview

16.2. South Korea Afluria Quadrivalent Market, Segmentation By Clinical Indication, Segmentation By Route Of Administration, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Afluria Quadrivalent Market

17.1. Western Europe Afluria Quadrivalent Market Overview

17.2. Western Europe Afluria Quadrivalent Market, Segmentation By Clinical Indication, Segmentation By Route Of Administration, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Afluria Quadrivalent Market

18.1. UK Afluria Quadrivalent Market, Segmentation By Clinical Indication, Segmentation By Route Of Administration, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Afluria Quadrivalent Market

19.1. Germany Afluria Quadrivalent Market, Segmentation By Clinical Indication, Segmentation By Route Of Administration, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Afluria Quadrivalent Market

20.1. France Afluria Quadrivalent Market, Segmentation By Clinical Indication, Segmentation By Route Of Administration, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Afluria Quadrivalent Market

21.1. Eastern Europe Afluria Quadrivalent Market Overview

21.2. Eastern Europe Afluria Quadrivalent Market, Segmentation By Clinical Indication, Segmentation By Route Of Administration, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Afluria Quadrivalent Market

22.1. North America Afluria Quadrivalent Market Overview

22.2. North America Afluria Quadrivalent Market, Segmentation By Clinical Indication, Segmentation By Route Of Administration, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Afluria Quadrivalent Market

23.1. USA Afluria Quadrivalent Market Overview

23.2. USA Afluria Quadrivalent Market, Segmentation By Clinical Indication, Segmentation By Route Of Administration, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Afluria Quadrivalent Market

24.1. Canada Afluria Quadrivalent Market Overview

24.2. Canada Afluria Quadrivalent Market, Segmentation By Clinical Indication, Segmentation By Route Of Administration, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Afluria Quadrivalent Market

25.1. South America Afluria Quadrivalent Market Overview

25.2. South America Afluria Quadrivalent Market, Segmentation By Clinical Indication, Segmentation By Route Of Administration, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Afluria Quadrivalent Market

26.1. Middle East Afluria Quadrivalent Market Overview

26.2. Middle East Afluria Quadrivalent Market, Segmentation By Clinical Indication, Segmentation By Route Of Administration, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Afluria Quadrivalent Market

27.1. Africa Afluria Quadrivalent Market Overview

27.2. Africa Afluria Quadrivalent Market, Segmentation By Clinical Indication, Segmentation By Route Of Administration, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Afluria Quadrivalent Market Regulatory and Investment Landscape

29. Afluria Quadrivalent Market Competitive Landscape And Company Profiles

29.1. Afluria Quadrivalent Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Afluria Quadrivalent Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Afluria Quadrivalent Market Company Profiles

29.3.1. Seqirus Inc. Overview, Products and Services, Strategy and Financial Analysis

30. Global Afluria Quadrivalent Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Afluria Quadrivalent Market

32. Afluria Quadrivalent Market High Potential Countries, Segments and Strategies

32.1 Afluria Quadrivalent Market In 2030 - Countries Offering Most New Opportunities

32.2 Afluria Quadrivalent Market In 2030 - Segments Offering Most New Opportunities

32.3 Afluria Quadrivalent Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Afluria Quadrivalent Market, Overview Of Key Products - Product Examples

Table 2: Global Afluria Quadrivalent Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Afluria Quadrivalent Market, Supply Chain Analysis

Table 4: Global Afluria Quadrivalent Market, Major Raw Material Providers

Table 5: Global Afluria Quadrivalent Market, Major Resource Providers

Table 6: Global Afluria Quadrivalent Market, Major Manufacturers (Suppliers)

Table 7: Global Afluria Quadrivalent Market, Major Distributors And Channel Partners

Table 8: Global Afluria Quadrivalent Market, Key Technologies & Future Trends

Table 9: Global Afluria Quadrivalent Market, Major Trends

Table 10: Global Afluria Quadrivalent Market, Major End Users

Table 11: Global Afluria Quadrivalent Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Afluria Quadrivalent Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Afluria Quadrivalent Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Afluria Quadrivalent Market - TAM, US$ Billion, 2025

Table 15: Global Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Afluria Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Afluria Quadrivalent Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Afluria Quadrivalent Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Afluria Quadrivalent Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: South Korea, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: South Korea, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: South Korea, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Western Europe, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Western Europe, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Western Europe, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: UK, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: UK, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: UK, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Germany, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Germany, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Germany, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: France, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: France, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: France, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Eastern Europe, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Eastern Europe, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Eastern Europe, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: North America, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: North America, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: North America, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: USA, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: USA, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: USA, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Canada, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Canada, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Canada, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: South America, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: South America, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: South America, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Middle East, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Middle East, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Middle East, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Africa, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Africa, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Africa, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Global Afluria Quadrivalent Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 74: Global Afluria Quadrivalent Market - Company Scoring Matrix

Table 75: Seqirus Inc. Financial Performance

Table 76: Global Afluria Quadrivalent Market, Competitive Benchmarking (In USD Billions)

Table 77: Global Afluria Quadrivalent Market, Competitive Dashboard

Table 78: Global Afluria Quadrivalent Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 79: Global, Afluria Quadrivalent Market Size Gain ($ Billion), Segmentation By Clinical Indication, 2025 – 2030

Table 80: Global, Afluria Quadrivalent Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Table 81: Global, Afluria Quadrivalent Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030

List Of Figures

Figure 1: Global Afluria Quadrivalent Market, Overview Of Key Products - Product Examples

Figure 2: Global Afluria Quadrivalent Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Afluria Quadrivalent Market, Supply Chain Analysis

Figure 4: Global Afluria Quadrivalent Market, Major Raw Material Providers

Figure 5: Global Afluria Quadrivalent Market, Major Resource Providers

Figure 6: Global Afluria Quadrivalent Market, Major Manufacturers (Suppliers)

Figure 7: Global Afluria Quadrivalent Market, Major Distributors And Channel Partners

Figure 8: Global Afluria Quadrivalent Market, Key Technologies & Future Trends

Figure 9: Global Afluria Quadrivalent Market, Major Trends

Figure 10: Global Afluria Quadrivalent Market, Major End Users

Figure 11: Global Afluria Quadrivalent Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Afluria Quadrivalent Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Afluria Quadrivalent Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Afluria Quadrivalent Market - TAM, US$ Billion, 2025

Figure 15: Global Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Afluria Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Afluria Quadrivalent Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Afluria Quadrivalent Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Afluria Quadrivalent Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: South Korea, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: South Korea, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: South Korea, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Western Europe, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Western Europe, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Western Europe, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: UK, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: UK, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: UK, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Germany, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Germany, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Germany, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: France, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: France, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: France, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Eastern Europe, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Eastern Europe, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Eastern Europe, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: North America, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: North America, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: North America, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: USA, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: USA, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: USA, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Canada, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Canada, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Canada, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: South America, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: South America, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: South America, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Middle East, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Middle East, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Middle East, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Africa, Afluria Quadrivalent Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Africa, Afluria Quadrivalent Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Africa, Afluria Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Global Afluria Quadrivalent Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 74: Global Afluria Quadrivalent Market - Company Scoring Matrix

Figure 75: Seqirus Inc. Financial Performance

Figure 76: Global Afluria Quadrivalent Market, Competitive Benchmarking (In USD Billions)

Figure 77: Global Afluria Quadrivalent Market, Competitive Dashboard

Figure 78: Global Afluria Quadrivalent Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 79: Global, Afluria Quadrivalent Market Size Gain ($ Billion), Segmentation By Clinical Indication, 2025 – 2030

Figure 80: Global, Afluria Quadrivalent Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Figure 81: Global, Afluria Quadrivalent Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Specialty Fertilizers Market Report 2026 - Global Outlook – By Type (Controlled Release Fertilizers, Water Soluble Fertilizers, Agricultural Micronutrients, Customized Fertilizers), By Crop (Cereals, Pulses And Oil Seeds...

Biomethane Market Report 2026 - Global Outlook – By Feedstock (Organic Household Waste, Animal Manure, Energy Crops, Agricultural Waste, Sewage Sludge, Industrial Food Processing Waste, Other Feedstocks), By Production M...

Calcium Aluminosilicate Market Report 2026 - Global Outlook – By Type (Cosmetics Grade, Pharmaceutical Grade, Industrial Grade, Food Grade), By Function (Adsorption, Ion Exchange, Anti-Caking, Stabilization), By Applicat...

Liquid Fertilizers Market Report 2026 - Global Outlook – By Type (Nitrogen, Micronutrients, Potassium, Phosphate), By Production Process (Organic, Inorganic), By Crop Type (Cereals And Grains, Oilseeds, Fruits, Pulses), ...

Fluorochemicals Market Report 2026 - Global Outlook – By Type (Fluorocarbons, Fluoroelastomers, Fluoropolymers, Inorganics, Other Types), By Application (Surfactants, Propellants, Aluminum Production, Refrigerant, Automo...

Quadrivalent Market Report 2026 - Global Outlook – By Type (Intradermal Shot, Intramuscular Injection, Nasal Spray), By Technology (Conjugated, Live, Inactivated, Recombinant, Toxoid, Other Technologies), By Disease (Can...

Biopreservation Market Report 2026 - Global Outlook – By Type (Biopreservation Equipment, Biopreservation Media), By Biospecimen (Human Tissue Samples, Organs, Stem Cells, Other Biospecimens), By Application (Therapeutic...

Frequently Asked Questions

How big is the Afluria Quadrivalent Market?

The Afluria Quadrivalent market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

What is the Afluria Quadrivalent market growth?

The global Afluria Quadrivalent market is expected to grow at a CAGR of nan% from 2026 to 2035 to reach $ billion by 2035.

Who are the key players in Afluria Quadrivalent market?

Some Key Players in the Afluria Quadrivalent market Include, Seqirus Inc. .

What is the anticipated growth trend for the Afluria Quadrivalent market?

Major trend in this market includes: nan. For further insights on this market. request a sample here

Which region has the most growth potential in the Afluria Quadrivalent market?

North America was the largest region in the afluria quadrivalent market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the afluria quadrivalent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.